Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Operating Expenses (2016 - 2025)

INVO Fertility has reported Operating Expenses over the past 15 years, most recently at $3.4 million for Q3 2025.

  • Quarterly Operating Expenses rose 24.11% to $3.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $32.1 million through Sep 2025, up 159.25% year-over-year, with the annual reading at $14.7 million for FY2024, 49.75% up from the prior year.
  • Operating Expenses was $3.4 million for Q3 2025 at INVO Fertility, down from $4.9 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $18.7 million in Q1 2025 and troughed at $1.9 million in Q3 2023.
  • The 5-year median for Operating Expenses is $2.8 million (2022), against an average of $3.8 million.
  • Year-over-year, Operating Expenses tumbled 32.58% in 2023 and then surged 507.74% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $2.5 million in 2021, then increased by 19.98% to $3.0 million in 2022, then decreased by 3.54% to $2.9 million in 2023, then soared by 78.19% to $5.2 million in 2024, then tumbled by 34.13% to $3.4 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Operating Expenses are $3.4 million (Q3 2025), $4.9 million (Q2 2025), and $18.7 million (Q1 2025).